| Combination therapy with anti–CTLA-4 and anti–PD-1 leads to distinct immunologic changes in vivo R Das, R Verma, M Sznol, CS Boddupalli, SN Gettinger, H Kluger, ... The Journal of Immunology 194 (3), 950-959, 2015 | 465 | 2015 |
| Early B cell changes predict autoimmunity following combination immune checkpoint blockade R Das, N Bar, M Ferreira, AM Newman, L Zhang, JK Bailur, A Bacchiocchi, ... The Journal of clinical investigation 128 (2), 715-720, 2018 | 330 | 2018 |
| Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma AL Garfall, EA Stadtmauer, WT Hwang, SF Lacey, JJ Melenhorst, ... JCI insight 3 (8), 2018 | 191 | 2018 |
| T cell ageing: effects of age on development, survival & function N Salam, S Rane, R Das, M Faulkner, R Gund, U Kandpal, V Lewis, ... Indian Journal of Medical Research 138 (5), 595-608, 2013 | 169 | 2013 |
| Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice R Das, T Strowig, R Verma, S Koduru, A Hafemann, S Hopf, MH Kocoglu, ... Nature medicine 22 (11), 1351-1357, 2016 | 148 | 2016 |
| Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells CS Boddupalli, N Bar, K Kadaveru, M Krauthammer, N Pornputtapong, ... JCI insight 1 (21), 2016 | 133 | 2016 |
| Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets K Sehgal, R Das, L Zhang, R Verma, Y Deng, M Kocoglu, J Vasquez, ... Blood, The Journal of the American Society of Hematology 125 (26), 4042-4051, 2015 | 127 | 2015 |
| Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy MV Dhodapkar, R Sexton, R Das, KM Dhodapkar, L Zhang, R Sundaram, ... Blood, The Journal of the American Society of Hematology 126 (22), 2475-2478, 2015 | 125 | 2015 |
| Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii J Vashist, V Tiwari, R Das, A Kapil, MR Rajeswari Indian Journal of Medical Research 133 (3), 332-338, 2011 | 122 | 2011 |
| SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer KM Dhodapkar, SN Gettinger, R Das, H Zebroski, MV Dhodapkar Oncoimmunology 2 (7), e25205, 2013 | 64 | 2013 |
| Checkpoint inhibition in myeloma: opportunities and challenges F Costa, R Das, J Kini Bailur, K Dhodapkar, MV Dhodapkar Frontiers in Immunology 9, 407928, 2018 | 60 | 2018 |
| Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer N Bar, F Costa, R Das, A Duffy, M Samur, S McCachren, SN Gettinger, ... JCI insight 5 (12), 2020 | 56 | 2020 |
| Naive CD4 T cells from aged mice show enhanced death upon primary activation H Mattoo, M Faulkner, U Kandpal, R Das, V Lewis, A George, S Rath, ... International immunology 21 (11), 1277-1289, 2009 | 24 | 2009 |
| Peripheral residence of naïve CD4 T cells induces MHC class II-dependent alterations in phenotype and function S Rane, R Das, V Ranganathan, S Prabhu, A Das, H Mattoo, JM Durdik, ... BMC biology 12, 1-19, 2014 | 7 | 2014 |
| Distinct dominant T-cell receptors with a tissue resident memory phenotype in individual melanoma metastases. KM Dhodapkar, CS Boddupalli, N Bar, K Kadaveru, M Krauthammer, ... Journal of Clinical Oncology 35 (7_suppl), 3-3, 2017 | 3 | 2017 |
| Niche-dependent growth of malignant and pre-neoplastic plasma cells in humanized mice R Das, T Strowig, R Verma, S Koduru, A Hafemann, S Hopf, MH Kocoglu, ... Blood, The Journal of the American Society of Hematology 126 (23), 120-120, 2015 | 2 | 2015 |
| Humanized Mouse Model of Myeloma Reveals Clinically Occult Genomic Changes in Primary Tumor Cells R Verma, T Strowig, R Das, S Koduru, A Hafemann, S Hopf, MH Kocoglu, ... Blood 126 (23), 22, 2015 | 1 | 2015 |
| Comparison of pomalidomide dosing strategies in lenalidomide-refractory myeloma: Impact on clinical outcome, immune activation and cereblon targets R Das, K Sehgal, L Zhang, R Verma, Y Deng, M Kocoglu, J Vasquez, ... Cancer Research 75 (15_Supplement), 1354-1354, 2015 | 1 | 2015 |
| Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer K Dhodapkar, R Verma, M Sznol, CS Boddupalli, S Gettinger, H Kluger, ... Journal for ImmunoTherapy of Cancer 2, 1-1, 2014 | 1 | 2014 |
| A role for MHC-mediated signalling in the functional and phenotypic heterogeneity of naive T cells (IRC8P. 454) S Rath, S Rane, R Das, R Gund, R Balyan, A Das, J Khalsa, ... The Journal of Immunology 194 (1_Supplement), 129.18-129.18, 2015 | | 2015 |
Boddupalli chandra sekharYale UniversityVerified email at yale.edu
